# Scandius BioMedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scandius-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Littleton, US
- Website: www.scandius.com
- Total disclosed funding: $12M
- Latest round: Series B (Jun 27, 2007)
- Investors on record: 4

## About

Scandius BioMedical specializes in innovative medical technology, focusing on developing advanced solutions for healthcare that enhance patient care and treatment outcomes.Founded in 2000 and based in Littleton, US, Scandius BioMedical focuses on healthcare innovations. The company was acquired by Covidien in November 2007 and has conducted a total of 3 deals. The latest funding round was Series B, securing USD 4.00 mn, with a current valuation of USD 20.31 mn. KBL Healthcare Ventures participated as an investor in this round.Scandius BioMedical offers a range of medical devices aimed at improving healthcare outcomes. Their products include advanced cardiovascular devices and diabetes management solutions, designed to serve healthcare providers and hospitals. The company aims to enhance patient quality of life through their innovative technologies, ensuring accessibility across various global markets.Scandius BioMedical generates revenue through direct sales to healthcare facilities and partnerships with distributors. Revenue primarily comes from flagship products that support chronic condition management, utilizing both direct-to-consumer and B2B sales strategies to reach healthcare providers effectively.Looking ahead, Scandius BioMedical plans to expand its product line by introducing new medical devices designed to address emerging healthcare needs. They are also targeting expansion into new markets, specifically in Europe and Asia-Pacific, projected for the next two years. The recent Series B funding of USD 4.00 mn will support these initiatives and enhance product development, positioning Scandius for future growth.

## Funding rounds

- Series B, Jun 27, 2007, $4M — KBL Healthcare Ventures
- Series C, Feb 23, 2005, $8M — NewSpring, KBL Healthcare Ventures, Ivy Capital Partners, Stockton Partners

## Investors

- NewSpring (https://capitalatlas.ai/funds/newspring) — Series C
- KBL Healthcare Ventures (https://capitalatlas.ai/funds/kbl-healthcare-ventures) — Series C, Series B
- Ivy Capital Partners (https://capitalatlas.ai/funds/ivy-capital-partners) — Series C
- Stockton Partners (https://capitalatlas.ai/funds/stockton-partners) — Series C